Presentation

La Rentabilidad de la TAVR frente al Tratamiento Estándar en Pacientes Inoperables con Estenosis Aórtica Grave

Presenter: M. Reynolds

February 12, 2012

REGISTER for free or LOG IN to view this content

La Rentabilidad de la TAVR frente al Tratamiento Estándar en Pacientes Inoperables con Estenosis Aórtica Grave

Structural Heart

Presentation

Up Next

Presentation Cell Therapy 2012

Trial 1: SCIPIO: Autologous Cardiac-Derived Stem Cells for LV Dysfunction

Presenter: Roberto Bolli

January 25, 2012

More slides +

Presentation Cell Therapy 2012

Differential Effects of Host Macrophages on the Survival and Function of Mesenchymal Stem Cells

Presenter: Donald Freytes

January 24, 2012

Presentation Cell Therapy 2012

Bioengineering Platforms for Stem Cell Delivery

Presenter: Gordana Vunjak-Novakovic

January 24, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.